Simvastatin (Zocor) Therapy in Sickle Cell Disease
Phase I/II Study of Simvastatin (Zocor) Therapy in Sickle Cell Disease
Sponsor: Department of Health and Human Services
A PHASE1/PHASE2 clinical study on Sickle Cell Disease, this trial is completed. The trial is conducted by Department of Health and Human Services and has accumulated 8 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Aug 2019 — Sep 2020 [monthly]
Completed PHASE1_PHASE2
▶ Show 3 earlier versions
-
Jun 2018 — Aug 2019 [monthly]
Completed PHASE1_PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE1_PHASE2
First recorded
Jun 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Department of Health and Human Services
- FDA Office of Orphan Products Development
- UCSF Benioff Children's Hospital Oakland
For direct contact, visit the study record on ClinicalTrials.gov .